Lataa...
Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction
Lung cancer represents the leading cause of cancer-related death in developed countries. Despite the advances in diagnostic and therapeutic techniques, the 5-year survival rate remains low. The research for novel therapies directed to biological targets has modified the therapeutic approach, but the...
Tallennettuna:
| Julkaisussa: | Cell Death Dis |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4454158/ https://ncbi.nlm.nih.gov/pubmed/25501825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2014.507 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|